Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Mar;35(3):243-8.
doi: 10.1007/BF00400924.

Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA

Affiliations

Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA

M Miralpeix et al. Diabetologia. 1992 Mar.

Abstract

Vanadate and insulin were administered to diabetic (streptozotocin) rats to compare their effects on the activity and mRNA content of 6-phosphofructo-2-kinase and L-type pyruvate kinase in the liver. The activity of 6-phosphofructo-2-kinase in livers of diabetic rats was about 40% of that found in normal rats. A similar decrease was found for 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase content, measured by immunoprecipitation, and for mRNA, measured by hybridization of Northern blots. Administration of vanadate to the diabetic rats led to a progressive recovery of 6-phosphofructo-2-kinase activity, and 6-phosphofructo-2-kinase/fructose- 2,6-bisphosphatase content and mRNA. This recovery, which was complete after 15 days of oral treatment, was also obtained after 60 h of insulin administration. L-type pyruvate kinase activity and mRNA were also decreased by about 70% in livers of diabetic rats. Both parameters normalized after 15 days of vanadate treatment, whereas insulin administration (60 h) raised L-pyruvate kinase mRNA three-fold above control values. Oral treatment for 15 days with vanadate can thus mimic the effect of insulin on both pyruvate kinase and 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase in livers of diabetic rats.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 1986 Apr 29;136(2):498-503 - PubMed
    1. J Clin Invest. 1991 Apr;87(4):1286-94 - PubMed
    1. Biochem J. 1987 Jul 15;245(2):313-24 - PubMed
    1. Eur J Biochem. 1989 Aug 1;183(2):433-40 - PubMed
    1. J Biol Chem. 1987 Feb 5;262(4):1810-7 - PubMed

Publication types

MeSH terms